Results

eNauka >  Results >  Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2
Title: Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2
Authors Tiede, Andreas; Janic, Dragana M  ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SR
Issue Date: 2018
Publication: Haemophilia. Special Issue: 11th Annual Congress of the European Association for Haemophilia and Allied Disorders 2018, 7–9 February 2018, Madrid, Spain February 2018
ISSN: 1351-8216 Haemophilia Search Idenfier
Publisher: Wiley Online Library
Type: Conference Paper
Collation: vol. 24 br. S1 str. 32-135
DOI: 10.1111/hae.13393
WoS-ID: 000423774100082
URI: https://enauka.gov.rs/handle/123456789/818452
URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/hae.13393
https://onlinelibrary.wiley.com/doi/10.1111/hae.13393
https://onlinelibrary.wiley.com/toc/13652516/2018/24/S1
Project: Alnylam
Baxter/Baxalta/Shire
Bayer
Biogen Idec
Biotest
CSL Behring
Novo Nordisk A/S
Octapharma
Pfizer
Roche
Sobi
Baxter
Shire
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.